Level 9 – MSC Pharmaceutical Technology- Emerging Trends CA 2025

Criteria Descripto r

Clarity on the analysis of the organisations
position in the pharmaceutical landscape- how was it achieved.

Clarity on the companys commitment 
to Innovation and the specific types of Innovation pursued

Clarity on the 4 products selected including 
their  tech. platforms, +/-, and

commercialization strategy.

Quality of references / 
referencing

Weighting to total 100

25

25

40

10

(80-100)

Exceptional clarity in the analysis of the organisation involved. Organisations position in the life science areas. Exceptional summary of the key challenges and themes based on a significant level of top quality research.

The submission demonstrates significant evidence of extensive reading of top-quality sources.

Exceptional clarity on the specific innovation issues that the company embraced and were facing.

Detail is very specific to the organisation and outlines where in the value stream it occurred and the impact is highlighted. Accurate Data is quoted and reference from top quality sources.

These are clearly demonstrated and discussed

Exceptional clarity on the specific actions these organisations undertook to address the 4 example products. Benefits of such actions are identified and quantified.

Examples show innovation and creativity. These are clearly demonstrated and discussed

Exceptional choice of relevant, top quality sources for the assignment.

All from peer reviewed

/credible sources. Absolutely central to the focus of the assignment.

(70-79)

Very good clarity in the analysis of the organisation involved. Very good summary of the key challenges and themes based on a mostly top quality research.

The submission demonstrates significant evidence of extensive reading of top-quality sources.

Very good clarity on the specific innovation issues that the company embraced and were facing.

Detail is very specific to the organisation and outlines where in the value stream it occurred and the impact is highlighted. Accurate Data is quoted and reference from top quality sources.

Very good clarity on the specific actions these organisations undertook to address the 4 example products . Benefits of such actions are identified and quantified.

Examples show innovation and creativity. These are clearly demonstrated and

discussed.

Very good choice of relevant, top quality sources for the assignment.

All from peer reviewed sources.

Absolutely central to the focus of the assignment.

Weighting

to total 100

25

25

40

10

These are clearly demonstrated and discussed

(60-69)

Good clarity in the analysis of the organisation involved. A good summary of the key challenges and themes based on a several top quality research. current and topical. The submission demonstrates evidence of reading of top- quality sources.

Good clarity on the specific innovation issues that the company embraced . Detail is specific to the organisation and products and outlines where in the value stream it occurred and the impact is highlighted. Some data is quoted and reference from mostly good quality sources. These are somewhat demonstrated and discussed .

Good clarity on the specific actions these organisations undertook to address the 4 example products

i. Benefits of such actions are somewhat identified and quantified. Some examples show innovation and creativity. These are demonstrated

and discussed fairly well .

Good choice of relevant, top quality sources for the assignment.

All from peer reviewed sources.

Absolutely central to the focus of the assignment.

(50-59)

Reasonable clarity in the analysis of the organisation involved. Reasonable summary of the key challenges and themes based on a mostly top quality research.

The submission demonstrates significant evidence of extensive reading of top-quality sources.

Reasonable clarity on the specific innovation issues that the company embraced and were facing.

Detail is very specific to the organisation and outlines where in the value stream it occurred and the impact is highlighted. Accurate Data is quoted and reference from top quality sources.

These are reasonably demonstrated and discussed

Reasonable clarity on the specific actions these organisations undertook to address the 4 example products . Benefits of such actions are identified and quantified.

Examples show innovation and creativity. These are reasonably demonstrated and discussed.

Reasonable choice of somewhat relevant quality sources. Some referenced are peer  reviewed. Of importance to the focus of the research but could have chosen a little more selectively.

(40-49)

Adequate clarity in the analysis of the organisation involved. Adequate summary of the key challenges and themes based on a mostly top quality research.

The submission demonstrates adequate evidence of extensive reading of top-quality sources. Evidence of research is very limited.

Adequate clarity on the specific innovation issues that the company embraced. There is very limited detail, or very generic (possible cut and paste) detail on where in the value stream the impact occurred and the impact is barely discussed. Some very limited data is quoted and reference from questionable sources. The discussion is very generic and very limited in value.

Adequate clarity on the specific innovation actions the organisations undertook . Some very limited benefits and actions are identified but require significant explanation. Some poor or limited examples show innovation and creativity. Most examples are generic in nature and limited in information.

Some of the sources are of relevance but the relevance and quality of many of the sources needs to be improved.

Needs to select more from peer reviewed sources.